Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
The Journal of Pathology|October 31, 2018
Decoding transcriptomic intra-tumour heterogeneity to guide personalised medicine in ovarian cancerTuan Zea Tan, Valerie Heong, Jieru Ye, et al.Communications Biology|August 3, 2019
The role of GRHL2 and epigenetic remodeling in epithelial-mesenchymal plasticity in ovarian cancer cellsVin Yee Chung, Tuan Zea Tan, Jieru Ye, et al.Molecular Cancer Therapeutics|October 29, 2014
Utilization of the Eμ-Myc mouse to model heterogeneity of therapeutic responseRachel E Rempel, Xiaolei Jiang, Paul Fullerton, et al.Molecular Oncology|December 15, 2018
The FZD7-TWIST1 axis is responsible for anoikis resistance and tumorigenesis in ovarian carcinomaMing Tan, Mohammad Asad, Valerie Heong, et al.Oncotarget|June 11, 2015
Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120)Ruby Yun-Ju Huang, Kuee Theng Kuay, Tuan Zea Tan, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 12, 2024
Spatial Profiling of Ovarian Clear Cell Carcinoma Reveals Immune-Hot FeaturesYa-Ting Tai, Wei-Chou Lin, Jieru Ye, et al.Scientific Reports|February 19, 2016
GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modificationVin Yee Chung, Tuan Zea Tan, Ming Tan, et al.The Journal of Pathology|July 29, 2021
A multi-ethnic analysis of immune-related gene expression signatures in patients with ovarian clear cell carcinomaValerie Heong, Tuan Z Tan, Maiko Miwa, et al.Gynecologic Oncology|October 16, 2024
Immunological impact of intraperitoneal and intravenous chemotherapy in ovarian cancer, translational analyses of the Phase 3 iPocc trialAiko Ogasawara, Hirokazu Matsushita, Tuan Zea Tan, et al.EMBO Molecular Medicine|May 14, 2013
Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancerTuan Zea Tan, Qing Hao Miow, Ruby Yun-Ju Huang, et al.Pageof 3